Zacks Investment Research Upgrades Grifols (NASDAQ:GRFS) to "Hold"
Grifols (NASDAQ:GRFS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous […]